Free Trial

OptiNose (OPTN) News Today

OptiNose logo
$9.60 0.00 (0.00%)
As of 05/21/2025

OPTN Latest News

OptiNose, Inc. stock logo
HC Wainwright Estimates OptiNose's Q2 Earnings (NASDAQ:OPTN)
OptiNose, Inc. (NASDAQ:OPTN - Free Report) - Investment analysts at HC Wainwright issued their Q2 2025 earnings estimates for OptiNose in a research note issued to investors on Monday, May 19th. HC Wainwright analyst M. Caufield forecasts that the company will earn ($0.75) per share for the quart
OptiNose, Inc. stock logo
OptiNose, Inc. (NASDAQ:OPTN) Shares Sold by D. E. Shaw & Co. Inc.
D. E. Shaw & Co. Inc. lessened its stake in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 93.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 333,333 shares of the company's stock after selling 4,666,667 s
Q2 Earnings Estimate for OptiNose Issued By HC Wainwright
OptiNose, Inc. stock logo
HC Wainwright Reiterates Neutral Rating for OptiNose (NASDAQ:OPTN)
HC Wainwright restated a "neutral" rating and issued a $9.00 price target on shares of OptiNose in a research note on Monday.
OptiNose, Inc. stock logo
OptiNose, Inc. (NASDAQ:OPTN) is Stonepine Capital Management LLC's 8th Largest Position
Stonepine Capital Management LLC lowered its stake in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 89.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 588,657 shares of the company's stock after selling 5,099,933 shares
OptiNose, Inc. stock logo
Bridgeway Capital Management LLC Sells 227,387 Shares of OptiNose, Inc. (NASDAQ:OPTN)
Bridgeway Capital Management LLC lowered its position in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 93.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,713 shares of the company's stock after selling 227,387 share
OptiNose, Inc. stock logo
OptiNose, Inc. (NASDAQ:OPTN) Shares Sold by Renaissance Technologies LLC
Renaissance Technologies LLC decreased its stake in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 94.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,748 shares of the company's stock after selling 214,252 shares
OptiNose, Inc. stock logo
OptiNose (OPTN) to Release Quarterly Earnings on Tuesday
OptiNose (NASDAQ:OPTN) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-optinose-inc-stock/)
OptiNose, Inc. stock logo
Bleichroeder LP Trims Position in OptiNose, Inc. (NASDAQ:OPTN)
Bleichroeder LP decreased its holdings in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 93.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 269,675 shares of the company's stock after selling 3,775,457 shares during the
OptiNose, Inc. stock logo
Geode Capital Management LLC Has $576,000 Stake in OptiNose, Inc. (NASDAQ:OPTN)
Geode Capital Management LLC reduced its position in shares of OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 93.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 86,167 shares of the company's stock after selling 1,
OptiNose, Inc. stock logo
Acorn Capital Advisors LLC Makes New $2.82 Million Investment in OptiNose, Inc. (NASDAQ:OPTN)
Acorn Capital Advisors LLC acquired a new stake in OptiNose, Inc. (NASDAQ:OPTN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 422,813 shares of the company's stock, valued at approximately $2,8
OptiNose, Inc. stock logo
OptiNose, Inc. (NASDAQ:OPTN) Shares Sold by MVM Partners LLC
MVM Partners LLC cut its holdings in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 93.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 973,684 shares of the company's stock after selling 13,631,579 shares during the quarter. Opti
OptiNose, Inc. stock logo
OptiNose, Inc. (NASDAQ:OPTN) Shares Sold by Nantahala Capital Management LLC
Nantahala Capital Management LLC reduced its stake in shares of OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 93.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 986,031 shares of the c
OptiNose, Inc. stock logo
GMT Capital Corp Decreases Stock Position in OptiNose, Inc. (NASDAQ:OPTN)
GMT Capital Corp reduced its position in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 93.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 74,047 shares of the company's stock after selling 1,036,655 share
OptiNose, Inc. stock logo
OptiNose, Inc. (NASDAQ:OPTN) Short Interest Update
OptiNose, Inc. (NASDAQ:OPTN - Get Free Report) saw a significant decline in short interest in March. As of March 31st, there was short interest totalling 191,700 shares, a decline of 29.5% from the March 15th total of 271,800 shares. Currently, 2.4% of the shares of the stock are sold short. Based on an average daily volume of 93,100 shares, the days-to-cover ratio is currently 2.1 days.
OptiNose, Inc. stock logo
Aster Capital Management DIFC Ltd Reduces Holdings in OptiNose, Inc. (NASDAQ:OPTN)
Aster Capital Management DIFC Ltd cut its stake in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 93.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,898 shares of the company's stock after selling 54
OptiNose, Inc. stock logo
Bank of New York Mellon Corp Sells 170,507 Shares of OptiNose, Inc. (NASDAQ:OPTN)
Bank of New York Mellon Corp decreased its holdings in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 93.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,178 shares of the company's stock after selling 170,507 shares during the quarter.
OptiNose, Inc. stock logo
OptiNose, Inc. (NASDAQ:OPTN) Position Reduced by Easterly Investment Partners LLC
Easterly Investment Partners LLC lessened its position in OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 98.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 46,667 shares of the company's stock after selling 2,312,572 shares during
OptiNose, Inc. stock logo
OptiNose (NASDAQ:OPTN) Releases Quarterly Earnings Results, Beats Expectations By $0.67 EPS
OptiNose (NASDAQ:OPTN - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.70) by $0.67. The firm had revenue of $21.47 million for the quarter, compared to analysts' expectations of $21.02 million.
Optinose reports Q4 EPS (3c) vs ($1.33) last year
OptiNose, Inc. stock logo
OptiNose (NASDAQ:OPTN) Cut to "Hold" at Piper Sandler
Piper Sandler downgraded shares of OptiNose from a "strong-buy" rating to a "hold" rating in a research report on Thursday.
OptiNose, Inc. stock logo
Piper Sandler Reiterates Neutral Rating for OptiNose (NASDAQ:OPTN)
Piper Sandler reissued a "neutral" rating and issued a $9.00 price objective (down from $15.00) on shares of OptiNose in a research note on Friday.
OptiNose, Inc. stock logo
OptiNose (NASDAQ:OPTN) Given Neutral Rating at HC Wainwright
HC Wainwright reissued a "neutral" rating and issued a $9.00 target price (down previously from $18.00) on shares of OptiNose in a report on Friday.
Optinose downgraded to Neutral from Buy at H.C. Wainwright
Optinose downgraded to Neutral from Overweight at Piper Sandler
Optinose downgraded to Hold from Buy at Lake Street
Lake Street Downgrades OptiNose (OPTN)
OptiNose, Inc. stock logo
OptiNose (NASDAQ:OPTN) Downgraded by Lake Street Capital to "Hold"
Lake Street Capital cut OptiNose from a "buy" rating to a "hold" rating in a report on Thursday.
OptiNose, Inc. stock logo
OptiNose (OPTN) Projected to Post Quarterly Earnings on Thursday
OptiNose (NASDAQ:OPTN) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.
OptiNose, Inc. stock logo
OptiNose, Inc. (NASDAQ:OPTN) CEO Sells $33,729.04 in Stock
OptiNose, Inc. (NASDAQ:OPTN - Get Free Report) CEO Ramy A. Mahmoud sold 6,376 shares of the stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $5.29, for a total value of $33,729.04. Following the completion of the sale, the chief executive officer now owns 126,931 shares in the company, valued at $671,464.99. This trade represents a 4.78 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Get OptiNose News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTN and its competitors with MarketBeat's FREE daily newsletter.

OPTN Media Mentions By Week

OPTN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPTN
News Sentiment

1.07

1.03

Average
Medical
News Sentiment

OPTN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPTN Articles
This Week

10

2

OPTN Articles
Average Week

Get OptiNose News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:OPTN) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners